Six Trends You’ll Want to Know in the IVD Market

Kalorama has released its 12th Edition of The Worldwide Market for In Vitro Diagnostic Tests.  It is a complete market study of the 69+ billion-dollar industry.   Among the report’s findings are the following: Some Improvement in European IVD Markets: Kalorama found reversed austerity, LDT spending, and test innovation increased Europe market size, somewhat.  As Europe is an important market, this boosted the IVD market as a whole. New […]

IVD Market Reaches $69.2 Billion

ARLINGTON, VA., The world market for diagnostics is estimated at $69.2 billion in 2019 and is expected to grow a little more than 4% annually to reach $85.2 billion by 2024. This is according to an upcoming report by market researcher Kalorama Information, part of Science and Medicine Group. This estimate includes all laboratory and […]

New Study Predicts 1,000+ Urgent Care Centers Opening in the US Over Next Five Years

A New study from Kalorama Information said that the number of urgent care centers in the US is expected to increase from approximately 10,600 currently to more than 12,000 by 2023. The report, The Market for U.S. Urgent Care projects a growing market for the urgent care center business and a growing market for suppliers […]

AACC 2019 Anaheim: A Demand for Faster, Better, and More Relevant Tests

Kalorama Information attended the American Association of Clinical Chemistry in Anaheim this year.    We analyzed products and trends, interviewed vendors and experts, and gathered information for our 12 Edition Worldwide Market for In Vitro Diagnostics Tests report, due out this month. Time is of the essence, it is said, and that was the case […]

Our Latest Report on Next-Generation Sequencing Finds Brisk Vendor Sales, but also Users With Unaddressed Needs

The DNA sequencer market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. It is a 4 billion […]

Introducing: The Kalorama Clinical Masterfile

Announcing a new product from Kalorama Information, Part of the Science and Medicine Group.  The  Kalorama Clinical Masterfile. For the best business results, clinical diagnostics marketers need knowledge about several elements: What products do my customers currently have? What types of products? Clinical Chemistry, Micro, Molecular, Immunoassays, Hematology? How old are those systems?  Is it […]

The World Market for Biomarkers

We have just published our latest report, The World Market for Biomarkers. Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, […]

Understanding the Clinical Diagnostics Customer Experience

We recently published a customer experience survey.  This blog highlights discusses the report and highlights the major findings of the report, including important recommendations for the clinical diagnostics industry.  For specific vendor performance and user ratings, a purchase of the report is suggested. Clinical laboratory customers have become increasingly sophisticated and typically have multiple suppliers […]

Milestone Reached for Kalorama Information under New Ownership as Part of Science and Medicine Group

Kalorama Information, a part of Science and Medicine Group, has announced that it has published its 25th report since the acquisition of the company by Science and Medicine Group. Since November, the firm has reported on food safety testing, infectious disease, Latin American Markets, molecular diagnostics and many other markets. “Experts in sequencing, liquid biopsy, […]

Red Flags Raised With CLIA Waived Test Growth

As reported on (Sign up at — Providers of proficiency testing for CLIA tests are becoming increasingly concerned about the lack of external quality control and oversight of CLIA-waived test kits, as the number of waived kits continues to expand. Some 1,400 waived test kits are now on the market, compared with 30 […]